Clinical Trial Update: A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial compares zanubrutinib plus rituximab against bendamustine plus rituximab in adults with previously untreated mantle cell lymphoma who are inelig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Treanda (Bendamustine)
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: BeiGene | Conditions: Mantle Cell Lymphoma; Non-Hodgkin Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING